Biognosys Launches Spectronaut 16 and Presents Major Advances to its Proteomics Platforms at the ASMS 2022 Annual Conference

Highlights include the launch of Spectronaut 16, which has undergone one of its most transformative upgrades to date, and innovations to Biognosys' proprietary TrueTarget and TrueDiscovery platforms

Related Keywords

United States ,Minnesota ,American ,Biognosys Truetarget ,Lukas Reiter ,Kostenloser Wertpapierhandel ,Birgit Schilling ,Oliver Bernhardt Biognosys ,Yves Serroen ,Biognosys Truediscovery ,Yansheng Liu Yale University School Of Medicine ,Johns Hopkins University ,Jesperv Olsen University Of Copenhagen ,Astrazeneca ,Proteolysis Mass Spectrometry ,American Society For Mass Spectrometry ,Buck Institute ,American Society ,Mass Spectrometry ,Annual Conference ,Chief Technology Officer ,Reaching New Depths ,Oliver Bernhardt ,Best Ally ,Visionary Projects ,Yansheng Liu ,Yale University School ,Systemic Lupus Erythematosus ,Pelago Bioscience ,Artificial Intelligence ,Machine Learning ,Hyper Reaction Monitoring ,Data Independent Acquisition ,Limited Proteolysis Mass Spectrometry ,Biognosys ,Aunches ,Pectronaut ,Presents ,Major ,Advances ,Roteomics ,Platforms ,Sms ,022 ,Nnual ,Conference ,